Pharma & Biotech

Recent securities filings reveal that BridgeBio Pharma's chief executive has executed substantial share sales during a period of exceptional stock...

Shares of Minerva Neurosciences experienced an unprecedented rally following the announcement of a substantial financing arrangement valued at up to...

The biotechnology sector is witnessing a remarkable performance from PTC Therapeutics, which is demonstrating substantial operational and financial progress. While...

The financial trajectory of Revolution Medicines presents a fascinating case study in biotech investing, where soaring research expenditures and mounting...

Biotechnology firm Xencor has given investors substantial reasons for optimism following a prolonged downturn. The company's latest quarterly report revealed...

Today marks a critical juncture for BioNTech as the German biotech firm unveils its strategic roadmap in New York. Investors...

In an investment landscape captivated by technological transformation, market participants are perpetually searching for the next frontier of expansion. Two...

Aclaris Therapeutics witnessed a significant selloff in its stock price after releasing disappointing third-quarter 2025 financial results. The biotechnology firm...

Investor attention is focused on BioAtla Inc following the release of compelling clinical trial results for its lead oncology asset,...

Protara Therapeutics, a clinical-stage biotechnology firm, delivered an impressive quarterly performance that has reignited market interest. The company not only...